Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Biochemical factor evaluation indicated that the lipid profile and vitamin D3 showed no significant difference between the two groups; however, the level of serum PTH was significantly (Mann: Whitney test p < 0.0001) higher in celiac patients (396.8 ± 7.33 pg/mL) compared to controls (300.1 ± 13.55 pg/mL).

Source: Higher Bone Remodeling Factors: PTH and Calcium in Celiac Patients. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A total of 43 cases and 45 controls were enrolled in this case‐control study.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Increased Serum Levels of Dickkopf‐1 and Sclerostin as WNT Signaling Pathway Inhibitors in Celiac Disease Patients

Case-control study · Immunity, Inflammation and Disease · 2026

Original publication title

Increased Serum Levels of Dickkopf‐1 and Sclerostin as WNT Signaling Pathway Inhibitors in Celiac Disease Patients

Mohammed Nibras Thabit Al‐Ani; Saad Kadhim Taher Yahya; Majid Dastorani; Hanie Mirkarimi; Sima Besharat; Marie Saghaeian Jazi

© 2026 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Celiac patients have increased levels of the Dkk‐1 and sclerostin, together with PTH as bone modulators, correlated with citrulline level, known as a potential marker for enterocyte mass. These results collectively indicate the significance of Dkk‐1 and sclerostin in the development of celiac disease; however, further research is needed to explore their possible diagnostic and therapeutic uses in the future.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To evaluate the level of two WNT antagonists, including dikkopf‐1 (Dkk‐1) and sclerostin, in CD patients compared to controls.

Source: Aim

Abstract: What methods does the paper describe?

A total of 43 cases and 45 controls were enrolled in this case‐control study. The serum levels of Dkk‐1, sclerostin, citrulline, and parathyroid hormone (PTH) were measured using the ELISA method. Moreover, the levels of vitamin D3 were measured using the HPLC method.

Source: Methods

Abstract: Result

Our findings illustrated an elevation of both WNT antagonists (Dkk‐1, p < 0.0001 and sclerostin, p = 0.002) in CD patients compared to controls. Moreover, the levels of PTH (p < 0.0001) and Ca (p = 0.009) were higher in CD patients. The level of citrullin was directly correlated with sclerostin (R = 0.71), PTH (R = 0.53), and Dkk‐1 (R = 0.29). ROC curve analysis indicated that serum levels of Dkk‐1 (AUC = 0.83), sclerostin (AUC = 0.7) and, PTH (AUC = 0.91) can differentiate CD from control.

Source: Result

Abstract: Conclusion

Celiac patients have increased levels of the Dkk‐1 and sclerostin, together with PTH as bone modulators, correlated with citrulline level, known as a potential marker for enterocyte mass. These results collectively indicate the significance of Dkk‐1 and sclerostin in the development of celiac disease; however, further research is needed to explore their possible diagnostic and therapeutic uses in the future.

Source: Conclusion
Authors’ abstract

ABSTRACT

Background

Celiac disease (CD) is an autoimmune enteropathy. The WNT signaling pathway acts in adult intestinal epithelium maintenance.

Aim

To evaluate the level of two WNT antagonists, including dikkopf‐1 (Dkk‐1) and sclerostin, in CD patients compared to controls.

Methods

A total of 43 cases and 45 controls were enrolled in this case‐control study. The serum levels of Dkk‐1, sclerostin, citrulline, and parathyroid hormone (PTH) were measured using the ELISA method. Moreover, the levels of vitamin D3 were measured using the HPLC method.

Result

Our findings illustrated an elevation of both WNT antagonists (Dkk‐1, p < 0.0001 and sclerostin, p = 0.002) in CD patients compared to controls. Moreover, the levels of PTH (p < 0.0001) and Ca (p = 0.009) were higher in CD patients. The level of citrullin was directly correlated with sclerostin (R = 0.71), PTH (R = 0.53), and Dkk‐1 (R = 0.29). ROC curve analysis indicated that serum levels of Dkk‐1 (AUC = 0.83), sclerostin (AUC = 0.7) and, PTH (AUC = 0.91) can differentiate CD from control.

Conclusion

Celiac patients have increased levels of the Dkk‐1 and sclerostin, together with PTH as bone modulators, correlated with citrulline level, known as a potential marker for enterocyte mass. These results collectively indicate the significance of Dkk‐1 and sclerostin in the development of celiac disease; however, further research is needed to explore their possible diagnostic and therapeutic uses in the future.

Publication and source details

Original title: Increased Serum Levels of Dickkopf‐1 and Sclerostin as WNT Signaling Pathway Inhibitors in Celiac Disease Patients

Mohammed Nibras Thabit Al‐Ani; Saad Kadhim Taher Yahya; Majid Dastorani; Hanie Mirkarimi; Sima Besharat; Marie Saghaeian Jazi

Immunity, Inflammation and Disease · 2026

* Correspondence: Marie Saghaeian Jazi (marie.saghaeian@goums.ac.ir)
© 2026 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. Golestan University of Medical Sciences10.13039/501100008091 112940‐113372

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:17:12.988706+00:00

DOI: 10.1002/iid3.70458 · PMC13171714